TrialThe Journal of clinical investigation2018

PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection.

Loghman Salimzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.